Emotion Regulation, Traumatic Brain Injury
Conditions
Brief summary
This is a hybrid type III implementation-effectiveness trial; this study design blends elements of implementation and clinical effectiveness research, with the primary aim of determining the utility of an implementation strategy and a secondary aim of assessing clinical outcomes associated with the implementation trial. Consistent with best practices for this type of design, the study team will conduct a randomized test of the effect of implementation strategy on effective delivery of the Online EmReg intervention in clinical practice. Specifically, the study team will compare Standard Training (a 3-hour on-demand training workshop) to Extended Training, (a 3-hour on-demand training workshop with 3 months of bi-weekly consultation). The research team's primary aim is to determine the optimal strategy to train clinicians in effectively delivering Online EmReg, and secondary aim is to assess patient improvement per clinician-administered DERS. Outcome measures will be assessed via self-report surveys, performance evaluations (via role-plays), and tracked clinician participation and fidelity. Study participation is expected to last up to 18 months.
Interventions
BEHAVIORALOnline EmReg
A Web-based group intervention to improve emotion regulation in individuals with traumatic brain injury (TBI). Online EmReg is a 3-hour on-demand training workshop
BEHAVIORALConsultation Sessions
3 months of bi-weekly consultation sessions
Sponsors
Icahn School of Medicine at Mount Sinai
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Licensed psychologist, social worker, or mental health counselor. * Training and experience in CBT, the framework for EmReg. * Experience working with people with TBI. * Experience providing group treatment. * A computer and internet to conduct group treatment via telehealth. * Actively treating ≥3 patients with TBI who are appropriate for EmReg (have emotion regulation difficulties based on clinician assessment). * Amenable to study tasks (e.g., completion of training, consultation, performance based role-play, data collection). * Not previously trained in EmReg. * Proficient in English.
Exclusion criteria
* Not willing to conduct group treatment via telehealth. * Non-English speaking.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Provider Self-Efficacy Scale Score | Up to 18 months | A 7-item Likert Scale (not at all confident (1) to fully confident (7)) adapted for use with EmReg to assess provider confidence in delivering core components of the Online EmReg intervention. Total scores range from 26 to 182. Higher values indicate a higher level of self-efficacy. Used in the literature to reliably predict implementation of evidence-based interventions. |
| Performance Evaluation (via Role Plays) | Post-3 hour EmReg training workshop | Assessed using a structured role play of EmReg groups in a simulated clinical setting. These role plays will be recorded and rated by a blinded evaluator. The evaluator will indicate the degrees to which the session goals were accomplished using a 15-item checklist. Each item will be rated a 0 (not introduced or covered), 1 (attempted/partially achieved), 2 (fully covered/achieved), or N/A (not applicable/relevant to session #). Participants can receive a total score of 0 to 30 on their performance-based role play. Higher values indicate higher achievement. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Training Satisfaction Rating Scale | Up to 18 months | Satisfaction with training will be assessed using the Training Satisfaction Rating Scale, a 12-item, 5-point Likert scale (higher scores = higher satisfaction). Total scores range from 12 to 60. Training engagement and consultation engagement (extended group only) will be tracked by study team. |
| Acceptability of Intervention Measure (AIM) | Up to 18 months | Provider's satisfaction with the intervention will be assessed using the Acceptability of Intervention Measure (AIM), a 4-item, 5-point Likert scale. Total scores can range from 4 to 20 with higher scores indicating greater acceptability. |
| Feasibility of Intervention Measure (FIM) Scale | Up to 18 months | Feasibility of the intervention will be assessed using the Feasibility of Intervention Measure (FIM), a 4-item, 5-point Likert scale. Total scores can range from 4 to 20 with higher scores indicating greater feasibility. |
| Intervention Appropriateness Measure (IAM) Scale | Up to 18 months | Appropriateness of the intervention will be assessed using the Intervention Appropriateness Measure (IAM), a 4-item, 5-point Likert scale. Total scores can range from 4 to 20 with higher scores indicating greater intervention appropriateness. |
| Number of EmReg groups scheduled and completed | Up to 18 months | The number of EmReg groups scheduled and completed by the clinician participants |
| Time between initial uptake and completion | Up to 18 months | The time between completion of training and initial uptake will be tracked. |
| Skills Acquisition Quiz for Providers (SAQ-P) | Up to 18 months | Clinician participants will be given a 25-item multiple-choice test of knowledge of Online EmReg training content. Correct answers are coded as 1 and incorrect answers are coded as 0. Scores range from 0-25 with higher scores indicating greater knowledge of the intervention. |
| Number of participants who receive treatment | Up to 18 months | Clinician participants will be asked to track the number of patients who receive treatment out of those who appear eligible. |
| Difficulties in Emotion Regulation Scale (DERS) | Up to 18 months | A 36-item questionnaire assessing capacity for emotion regulation. Each item is scored on a 5-point scale. Total scores range from 80 to 136. Out of the 36 items, 11 are reverse scored. Higher scores suggest greater problems with emotion regulation. |
Countries
United States
Contacts
CONTACTEmily Blunt, BA
CONTACTAnnell Ovalles, MPH
PRINCIPAL_INVESTIGATORMaria Kajankova, PhD
Icahn School of Medicine at Mount Sinai
Outcome results
None listed